- STAT+: Up and down the ladder: The latest comings and goingsFrom new hires to departures, promotions, and hires, here are the latest comings and goings in the pharma industry.STAT · 4d ago↗ source
- Amgen sheds around 40 staffers amid continuing strugglesAmgen has laid off around 40 employees as part of “organizational changes” meant to better align operations with the company’s strategic objectives, Fierce has learned.Fierce Biotech · 4d ago↗ source
- Sanofi halts development of troubled immune drug in eczemaThe decision to no longer seek approval of amlitelimab is the latest setback for a treatment once hailed as a future blockbuster. One analyst expects Sanofi to now pursue “strategic action” to boos…BioPharma Dive · 4d ago